login | register

An analysis of the utilisation and expenditure of medicines dispensed for the prophylaxis and treatment of osteoporosis

Publisher: 
National Centre for Pharmacoeconomics
Author: 
National Centre for Pharmacoeconomics
Date published: 
3 February, 2007
Region: 
Republic of Ireland

Publication type: 
research

Osteoporosis is a skeletal disease characterised by low bone mass and microarchitectural deterioration with a resulting increase in bone fragility and therefore increased risk of fracture[1]. It occurs predominantly in postmenopausal women and in patients who are taking long-term oral corticosteroids (glucocorticosteroids)[2]. Other factors which increase the risk of developing osteoporosis are low body weight, cigarette smoking, excess alcohol intake, lack of physical activity, family history of osteoporosis and early menopause.

Back to top